当前位置:首页 - 行情中心 - 大唐药业(920433) - 财务分析 - 现金流量表

大唐药业

(920433)

  

流通市值:11.48亿  总市值:17.35亿
流通股本:1.69亿   总股本:2.56亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金127,536,590.1991,304,89156,115,946.98183,325,082.22
  收到其他与经营活动有关的现金5,966,161.53,527,833.9394,686.7921,531,914.17
  经营活动现金流入小计133,502,751.6994,832,724.956,510,633.77204,856,996.39
  购买商品、接受劳务支付的现金32,049,948.3923,773,684.6213,861,967.6138,931,158.51
  支付给职工以及为职工支付的现金27,308,574.9218,584,193.529,116,034.6831,987,616.96
  支付的各项税费13,184,998.4111,954,804.244,964,085.8213,683,693.47
  支付其他与经营活动有关的现金66,373,363.3839,023,245.3217,672,045.0893,876,291.98
  经营活动现金流出小计138,916,885.193,335,927.745,614,133.19178,478,760.92
  经营活动产生的现金流量净额-5,414,133.411,496,797.210,896,500.5826,378,235.47
二、投资活动产生的现金流量:
  收回投资收到的现金117,000,00080,000,00030,000,00057,300,000
  取得投资收益收到的现金5,162,964.064,987,142.033,150,000337,973.6
  投资活动现金流入小计122,162,964.0684,987,142.0333,150,00057,637,973.6
  购建固定资产、无形资产和其他长期资产支付的现金17,786,925.5813,797,448.814,390,055.3662,946,769.28
  投资支付的现金94,300,00065,300,0005,300,00042,300,000
  投资活动现金流出小计112,086,925.5879,097,448.819,690,055.36105,246,769.28
  投资活动产生的现金流量净额10,076,038.485,889,693.2223,459,944.64-47,608,795.68
三、筹资活动产生的现金流量:
  取得借款收到的现金67,520,870.9340,979,690.9422,488,606.1286,457,362.64
  收到其他与筹资活动有关的现金---1,171,000
  筹资活动现金流入小计67,520,870.9340,979,690.9422,488,606.1287,628,362.64
  偿还债务支付的现金67,086,378.7749,804,378.7735,030,940.77126,941,748.41
  分配股利、利润或偿付利息支付的现金16,994,284.3116,404,209.73521,592.0823,990,061.91
  支付其他与筹资活动有关的现金---4,424,845.21
  筹资活动现金流出小计84,080,663.0866,208,588.535,552,532.85155,356,655.53
  筹资活动产生的现金流量净额-16,559,792.15-25,228,897.56-13,063,926.73-67,728,292.89
四、汇率变动对现金及现金等价物的影响-702.15424.9886.28894.92
五、现金及现金等价物净增加额-11,898,589.23-17,841,982.1621,292,604.77-88,957,958.18
  加:期初现金及现金等价物余额31,691,813.4831,691,813.4831,691,813.48120,649,771.66
  期末现金及现金等价物余额19,793,224.2513,849,831.3252,984,418.2531,691,813.48
补充资料:
  净利润--21,901,231.33-10,536,494
  资产减值准备-2,099,061.26-2,761,471.02
  固定资产和投资性房地产折旧-15,368,077.34-22,201,954.49
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-15,368,077.34-22,201,954.49
  无形资产摊销-306,771.31-613,542.36
  长期待摊费用摊销-796,096.3-796,096.3
  公允价值变动损失--166,614.41--123,995.34
  财务费用--1,456,663.05-1,696,496.5
  投资损失--308,868.06--1,827,592.97
  递延所得税--3,363,115.11--579,771.76
  其中:递延所得税资产减少--3,370,324.18--533,102.22
    递延所得税负债增加-7,209.07--46,669.54
  存货的减少--232,173.35--
  经营性应收项目的减少-1,370,519.45--29,732,686.54
  经营性应付项目的增加-7,822,832.23-19,371,663
  现金的期末余额-13,849,831.32-31,691,813.48
  减:现金的期初余额-31,691,813.48-120,649,771.66
  现金及现金等价物的净增加额--17,841,982.16--88,957,958.18
公告日期2025-10-292025-08-272025-04-252025-04-25
审计意见(境内)标准无保留意见
TOP↑